Drug Profile
Alogliptin/metformin - Takeda
Alternative Names: Alogliptin benzoate/metformin hydrochloride; Inisync; KAZANO; Kazano; Metformin/alogliptin; Nesina Met; SYR-322/metformin; SYR-322MET; TAK-322/metformin; VipdometLatest Information Update: 07 Mar 2021
Price :
$50
*
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Benzonitrile; Biguanides; Piperidines; Pyrimidinones; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus